P2Y12 inhibitors during and after acute coronary syndrome, where do we stand in 2020?
Reloading patients chronically treated with P2Y12 inhibitors and presenting with ACS/PCI: Facing a crossroad? - International Journal of Cardiology
![PDF] A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a00275204b744cd63f1a792ad9748b856dc6bc2b/5-Figure1-1.png "PDF] A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI. | Semantic Scholar")
PDF] A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI. | Semantic Scholar
Antiplatelet therapy in coronary artery disease
Optimal pharmacological therapy in ST-elevation myocardial infarction—a review | SpringerLink
P2Y12 inhibitors during and after acute coronary syndrome, where do we stand in 2020?
Favorable net clinical benefit with P2Y12 inhibitor in addition to aspirin in CAD patients with T2DM and prior PCI - PACE-CME
Tailoring P2Y12 Inhibiting Therapy in Elderly Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention | Journal of the American Heart Association
60221-2.fp.png "P2Y12 RECEPTOR INHIBITION ACCORDING TO PREHOSPITAL ADMINISTRATION OF TICAGRELOR IN PRIMARY PCI FOR ST ELEVATION MYOCARDIAL INFARCTION: THE PRIVATE-ATLANTIC STUDY | Journal of the American College of Cardiology")
P2Y12 RECEPTOR INHIBITION ACCORDING TO PREHOSPITAL ADMINISTRATION OF TICAGRELOR IN PRIMARY PCI FOR ST ELEVATION MYOCARDIAL INFARCTION: THE PRIVATE-ATLANTIC STUDY | Journal of the American College of Cardiology
Multivessel Versus Culprit-only Percutaneous Coronary Intervention in ST-segment Elevation Acute Myocardial Infarction: Analysis of an 8-year Registry | Revista Española de Cardiología (English Edition)
Stentless strategy in primary PCI setting: An alternative strategy in some clinical scenarios? - ScienceDirect
Dual Antiplatelet and Glycoprotein Inhibitors in Emergency PCI | SpringerLink
Poll Results: Preload With P2Y12 Inhibitor - American College of Cardiology
Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial.,JAMA - X-MOL
Initial and long-term management of acute coronary syndromes in the UK.... | Download Scientific Diagram
Current guideline recommendations on P2Y 12 receptor directed treatment... | Download Table
Proposed use of P2Y12 inhibitors - ppt download
Comparison of Dabigatran Plus a P2Y12 Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI - The American Journal of Medicine
stemi
Meta-Analysis of the Efficacy and Safety of Genotype-Guided Strategy for Selection of P2Y12 Inhibitors in Coronary Artery Disease - American Journal of Cardiology
PDF) Pre-treatment with P2Y12 inhibitors in ACS patients: Who, when, why, and which agent?
Myo.infarction
